Vellgus Red Light Team

Primary Amoebic Meningoencephalitis (PAM), caused by the free-living amoeba Naegleria fowleri, represents one of the most devastating and rapidly fatal infections known to medicine. Often referred to as the “brain-eating amoeba,” it is found in warm freshwater environments and enters the…

Babesia, a malaria-like parasitic infection transmitted by ticks, presents a formidable challenge in the realm of vector-borne diseases. Unlike Lyme disease, which is caused by a bacterium, Babesia invades red blood cells, leading to a complex array of symptoms including…

Trypanosoma cruzi, the protozoan parasite responsible for Chagas disease, remains a significant public health challenge, affecting an estimated 6 to 7 million people worldwide . Current chemotherapeutic options, primarily benznidazole and nifurtimox, are associated with substantial toxicity and variable efficacy, particularly…

Cutaneous leishmaniasis (CL) remains a neglected parasitic disease with significant global morbidity, particularly in endemic regions across South America, Asia, and Africa. Conventional treatments, including pentavalent antimonials and miltefosine, present challenges ranging from parenteral administration and toxicity to emerging drug…

Trichomonas vaginalis infection remains the most prevalent non-viral sexually transmitted infection worldwide, with approximately 156 million new cases annually. While nitroimidazoles such as metronidazole represent the current standard of care, emerging resistance and treatment-associated adverse effects have created an urgent need…

Abstract: Cryptosporidium parvum, a chlorine-resistant protozoan parasite, remains a significant challenge in water treatment and immunocompromised patient care. While ultraviolet (UV) irradiation has demonstrated efficacy against oocyst infectivity, the potential role of photobiomodulation (PBM) and red light therapy in managing cryptosporidiosis…

Entamoeba histolytica, the protozoan parasite responsible for amebiasis, remains a significant cause of morbidity and mortality worldwide, particularly in developing regions with inadequate sanitation. While conventional pharmacotherapy with nitroimidazoles and luminal agents remains the standard of care, rising concerns regarding…

Toxoplasma gondii is a pervasive intracellular parasite infecting up to one-third of the global population. While acute infection is often managed with antimicrobials, chronic latent infection has been linked to neuroinflammation, behavioral changes, and neuropsychiatric disorders. Recently, Red Light Therapy…

Can red light therapy treat Toxoplasma gondii? Explore the emerging science, potential mechanisms, doctor insights, and how photobiomodulation might combat this stubborn parasitic infection.